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A B S T R A C T
Low values on heart rate variability (HRV) derived parameters at resting have been used to predict 
cardiovascular diseases (CVD) and mortality. In this regard, short-term HRV recordings (usually from 
5 to 15 minutes) are increasing their popularity because data acquisition can be performed under 
more controlled conditions than long-term recordings (e.g., 24 hours). However, different method-
ological aspects before, during, and after the HRV assessment could affect the quantification and 
the clinical interpretations of the HRV-derived parameters, as well as hamper comparisons across 
different studies. In the present study, we summarize these methodological aspects that should be 
considered in both the research and the clinical settings. These are: (1) the validity and reproducibility 
of the device used to assess the HRV; (2) the influence of the software used to perform the artefact 
correction; (3) previous conditions before the testing day; (4) establishing the proper conditions 
during the HRV assessment (e.g., controlled respiratory frequency); (5) after assessing the HRV, con-
sidering the “best” data selection and statistical analysis approach; and (6) the role of the heart rate 
on the associations between the different CVD risk factors outcomes (e.g., cardiorespiratory fitness) 
and the HRV-derived parameters.
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Heart rate variability (HRV) is a non-invasive indicator of 
cardiac autonomic modulation, which reflects the variation 
in the time intervals between consecutive normal-to-nor-
mal R-R intervals [1]. The HRV is commonly expressed using 
different parameters in time and frequency domains [1, 2]. 
In most cases, reduced HRV-derived parameters values, 
while the subject is in at resting state (e.g., lying on a bed), 
are associated with a higher risk of cardiovascular disease 
(CVD) and mortality [1, 3–5].
Different methodological aspects should be considered 
to properly derive the HRV parameters and to determine its 
clinical interpretations. An example could be the duration 
of the HRV assessment (e.g., 5 min period vs 24 h period of 
R-R signal recording), the method or the instrument used 
(e.g., heart rate monitor [HRM] vs electrocardiography 
[ECG]) for the assessment, and, in the final step, the pro-
cedure followed for the data selection and/or processing. 
In this regard, the duration of the HRV recordings could 
directly influence the quantification of some of the HRV-de-
rived parameters in the time domain such as the standard 
deviation of the normal R-R intervals (SDNN) [1]. This is 
mainly produced because the total variance of the HRV is 
directly related to the duration of the HRV recording [1]. 
Importantly, in the last years, short-term HRV recordings 
(commonly from 5 to 15 minutes periods) using HRM are 
increasing in popularity [2, 6, 7]. One of the reasons is that 
short-term HRV recordings allow to obtain meaningful 
and accurate data under more controlled conditions (e.g., 
reducing confounder factors, such as body positioning or 
respiratory rate, etc.), compared to the long-term or the 
24 h period of R-R signal recordings [2, 6].
Another methodological example which has a direct 
impact on the quantification of the HRV-derived pa-
rameters is the researcher [6]. Prior to deriving the HRV 
parameters, the R-R signal requires the researcher to 
make certain “subjective decisions” that could impact the 
quantification of the HRV parameters [6]. However, this R-R 
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signal data processing is a mandatory step, as in most R-R 
signal recordings (independently of the instrument used 
for the recording, i.e., HRM or ECG) artifacts occur [8]. This 
procedure of removing (or interpolating) the R-R signal 
artefacts present in the signal is commonly known as the 
“artefact correction procedure” [7, 8]. If those artefacts are 
not removed (or interpolated), they could directly influence 
the HRV-derived parameters producing either under- or 
over-estimations up to 50% [9]. There are several ways to 
overcome these “artefacts-related” problems, e.g., in the 
Kubios software, i.e., one of the most commonly used the 
HRV analytical tools (HRV analysis, University of Eastern Fin-
land), different levels of threshold-based artefact filters may 
be employed depending on the artefact amount (so-called 
“Kubios filters”) [7, 10]. However, it has been shown that the 
Kubios filters may influence the HRV-derived parameters 
from short-term recordings in both the time and frequency 
domains especially in young populations [7].
Lastly, an inverse and non-linear relationship between 
the HRV-derived parameters and the average heart rate 
(HR) exists [11]. Therefore, HR should be considered when 
the HRV analyses are performed [12]. Briefly, it has been 
shown that changes in HR might produce alterations in the 
HRV-derived parameters due to mathematical influences 
[11]. Moreover, it has been suggested that the inter-sub-
jects differences in the HRV-derived parameters could be 
explained, to a greater or lesser extent, by their differences 
in HR [12, 13].
This narrative review aimed at summarizing differ-
ent methodological considerations that may influence 
the quantification, and the clinical interpretation of the 
HRV-derived parameters assessed from resting short-term 
recordings. 
HRV-DERIVED PARAMETERS IN TIME AND 
FREQUENCY DOMAINS
The parasympathetic and sympathetic nervous systems 
are considered the main determinants of the HRV-derived 
parameters in time and frequency domains [14]. Howev-
er, human physiology is complex and HRV is considered 
a physiological variable that could reflect the complex 
interaction among several physiological systems such as 
endocrine, respiratory, and immunological, among other 
systems [15]. The most common HRV-derived parameters 
in the time domain (Table 1) are considered as indicators 
of vagal tone, and lower values at resting conditions are 
associated with a higher risk of CVD and mortality [3, 4, 
15]. Importantly, although the HRV-derived parameters in 
the time domain reflect vagal tone, they cannot determine 
if reductions in the variations of the R-R intervals (or the 
HRV-derived parameters) are produced by an increase in 
the sympathetic tone or by a decrease in the vagal tone [15].
First, it should be noted that not all the parameters 
can be used “appropriately” when the data is derived from 
short-term recordings [1]. In Table 1 we introduced the 
most used HRV-derived parameters using data from short-
term recordings performed with the subject resting [1, 
16]. The HRV-derived parameters in the frequency domain 
(Table 1) allow researchers to determine the cyclic fluctu-
ations of the R-R intervals [2, 15]. For that purpose, the R-R 
signal is divided into different frequency bands. The high 
frequency (HF) band (0.15–0.40 Hz), is an indicator of vagal 
tone and is also called the “respiratory band” [2, 17]. Nota-
bly, the HRV-derived parameters that indicate vagal tone 
in the time domain — the squared root of the mean of the 
sum of the squares of successive normal R-R interval dif-
ferences (RMSSD), and the percentage of pairs of adjacent 
normal R-R intervals differing by more than 50 milliseconds 
during the entire recording (pNN50) — are strongly and 
positively associated with the HF band [1,18]. Then, we 
find the low frequency (LF) band (0.04–0.15 Hz), which 
is influenced by the parasympathetic and sympathetic 
control, making clinical and physiological interpretations 
difficult [1, 19, 20]. In the previous literature it has been 
suggested that the LF band could be used as an indicator 
of sympathetic tone [21]. However, the LF band has not 
been related to sympathetic nervous responses which are 
associated with different acute stimuli [21]. In this regard, 
exercise and myocardial ischemia reduced the LF band 
instead of increasing it, thus the LF band has been consid-
ered a “poor” indicator of sympathetic tone [20]. Similarly, 
the ratio of LF to HF (LF:HF) is commonly considered as an 
indicator of sympatho-vagal balance (e.g., sympathetic 
activation is accompanied by a reduction of vagal tone). 
Nevertheless, this “simple” interpretation does not consider 
the non-linear and complex relationship between the par-
asympathetic and the sympathetic nervous systems [19]. 
Therefore, considering these reasons, the ratio LF:HF should 
not be used as an indicator of sympatho-vagal balance [19].
Lastly, the non-linear analysis, and thus its derived 
parameters, could better describe the complex non-linear 
interactions between parasympathetic and sympathetic 
nervous system branches and the behavior of the varia-
tions among R-R intervals. However, understanding the 
Table 1. Most used heart rate variability (HRV) derived parameters
HRV-derived parameter Parameter description
Time domain
RMSSD, ms Square root of the mean of the sum of the 
squares of successive normal R-R interval 
differences
SDNN, ms Standard deviation of all normal R-R intervals
pNN50, % Percentage of pairs of adjacent normal R-R 
intervals differing by more than 50 ms in the 
entire recording
Frequency domain
HF, absolute units; ms2 The absolute power of the HF band (HF: 
0.15–0.4 Hertz)
LF, absolute units; ms2 The absolute power of the LF band (LF: 
0.04–0.15 Hertz)
Ratio LF:HF The ratio of LF to HF
All descriptions of HRV derived parameters are extracted from Plaza-Florido et al. 
[16] and/or Task Force Report [1].
Abbreviations: HF, high frequency; LF low frequency; R-R interval, the time between 
R peaks on electrocardiograms; ms, milliseconds
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HRV-derived parameters in non-linear domains is more 
difficult (e.g., entropy and fractal parameters) than either 
time or frequency domains, and their physiological and 
clinical implications remain unclear [2, 22]. In this regard, 
more studies are needed to reveal the physiological and 
autonomic regulation mechanisms underlying the chang-
es in different HRV-derived parameters in the non-linear 
domain under different conditions and scenarios (e.g., 
mental stress, diverse pathologies, physical exercise, etc.). 
In addition, non-linear parameters should be derived from 
long ECG traces, and indeed little is known about their 
clinical values  from short-term recordings, so they are not 
discussed in detail in this article.
R-R SIGNAL ASSESSMENT:  
VALIDITY AND REPRODUCIBILITY  
OF HEART RATE MONITORS
The International Bureau of Weights and Measures defines 
validation as “verification (i.e., provision of objective evi-
dence), where the specified requirements are adequate for 
an intended use” [23]. Therefore, the concept validity refers 
to how accurately a device, a method, or a technique “assess 
what is intended to be assessed”. On the other hand, for 
monitoring changes over time, the method used must be 
reproducible (a concept also found in literature as reliable 
or reliability) [24]. Although readers could find diverse 
definitions of reproducibility, for simplicity, we will herein be 
referring to it as “the degree of similarity between measure-
ments performed under the same conditions at different 
times”. In other words, how repeated measures under the 
same testing conditions vary (or not) for the individuals.
The measurement of the R-R signal usually demands 
a high-quality ECG, which is considered the ‘gold standard’ 
(i.e., the reference) device [1] and an electrocardiogram 
(sampling rate ≥500 Hz), plus an algorithm that allows 
detecting the QRS complex accurately [1]. In recent years, 
and aiming at satisfying these necessities, diverse ambu-
latory ECG and Holter monitors have been developed and 
manufactured [25]. Unfortunately, the equipment’s relative 
difficulty and cost have, somehow, made the acquisition 
and processing of the R-R signal and the HRV parameters 
challenging outside the clinical and research settings [26]. 
To overcome these limitations, diverse user-friendly wire-
less HRMs equipped with an adjustable elastic electrode 
belt have been developed, allowing for both R-R signal 
detection and recording. 
Most studies have reported a similar concordance be-
tween HRMs and ECGs. The most studied brand in the cur-
rent literature is probably Polar® (Polar Electro OY, Kempele, 
Finland) and its different HRM models (e.g., Polar RS800CX™, 
S810™, etc.). In general terms, the aforementioned HRM 
models have shown an acceptable validity [27–33], or, in 
other words, a good level of agreement compared to the 
‘gold standard’ method. Nevertheless, some other studies 
have observed a low validity [34] of the HRM. Importantly, 
it has been suggested that those results could be related to 
the software used for deriving the HRV parameters instead 
of the HRM itself [35].
In summary, studies assessing both the validity and the 
concordance among different HRM models and brands are 
mandatory for a better understanding of the HRV-derived 
parameters (estimated from short-term recordings) and 
their clinical and practical implications. Importantly, the 
software used to process the R-R signal should be con-
sidered, as it may influence the conclusions [35]. It should 
be highlighted that other validation studies have also 
been performed in different conditions, for example, in 
non-healthy individuals (e.g., [36] — the autors observed 
that the R-R signal measured using HRM and a 12-lead 
electrocardiograph is comparable) or during exercise (e.g., 
[37, 38] — the autors observed that HRM is a valid device 
compared to a 12-lead electrocardiograph in endurance 
athletes while running [37], and that the Polar HRM meas-
ures are comparable to an electrocardiograph during dif-
ferent intensities exercises [38]). However, as we mentioned 
earlier, the present study is focused on methodological 
considerations for subjects at a resting state.
It should be noted that, in short-term HRV recordings 
(even employing ECG), the difficulty is that the same subject 
shows the exact same level of autonomic nervous system 
modulation at different times (e.g., day-to-day). However, 
achieving a high day-to-day reproducibility is fundamental 
for analyzing and detecting the magnitude of change in 
the HRV-derived parameters over a period of time (e.g., 
before vs after an intervention). Previous reviews have 
suggested that HRV-derived parameters are, to a greater 
or lesser extent, reproducible [39, 40], although this gener-
alization might not be suitable for certain populations. For 
example, the HRV-derived parameters seem to be less re-
producible in unhealthy compared to healthy populations 
[24]. Therefore, it is important to know the reproducibility 
of the HRV parameters, as this will allow to compare the 
results obtained at different time points (under the same 
conditions) with a certain degree of confidence.
A relatively recent study [28] tested the day-to-day 
reproducibility (each test was performed 2 weeks apart at 
the same time of day) of different HRV-derived parameters 
in time and frequency domains assessed using an HRM 
under diverse orthostatic conditions (sitting and standing). 
In brief, their results were similar to those reported by 
Sandercock et al. [24] in their systematic review. They also 
observed a moderate reproducibility of the HRV-derived 
parameters during the abovementioned conditions after 
reviewing the literature [24]. Comparing the conditions (i.e., 
sitting vs standing), Williams et al. [28] observed a better 
reproducibility for the LF band than the HF band (under 
free-breathing conditions), which agreed with the results 
showed by Pitzalis et al. [41]. Furthermore, Williams et al. 
[28] demonstrated that the reproducibility of frequency 
domain HRV-derived parameters may be influenced by 
the spectral analysis algorithm used (i.e., autoregressive 
[AR] vs fast Fourier Transform [FFT]). Therefore, caution 
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is needed when comparing reproducibility results across 
studies using different spectral analysis algorithms as the 
comparisons may be biased. These results were in agree-
ment with those obtained by Pichon et al. [42] (healthy 
adults) and by Chemla et al. [43] (unhealthy populations). 
This reinforces the idea that although AR and FFT provide 
‘the same end-point’ (i.e., analyze the R-R signal), they 
should not be considered as interchangeable options [28] 
due to the discrepancies showed in the aforementioned 
studies. However, other studies [44–46] have suggested 
that AR and FFT algorithms provided similar reproducibility 
results in adolescents and adults. Therefore, more studies 
are needed addressing this comparison of AR vs FFT algo-
rithms across different cohorts to elucidate the source of 
these disagreements. On the other hand, previous studies 
[6, 44] have reported that short-term HRV-derived parame-
ters in  the time domain (e.g., RMSSD) have shown a higher 
reproducibility compared to the short-term HRV-derived 
parameters in the frequency domain (e.g., HF band) in 
young populations. Moreover, HRV-derived parameters 
repeatability is affected by changes in mean HR, and even 
a minimal change in mean HR can significantly change 
HRV-derived parameters, therefore this aspect should be 
taken into account when assessing R-R signal in the same 
patient [47, 48].
Finally, although some HRV-derived parameters seem 
more reproducible than others, studies analyzing this issue 
sometimes used different cohorts, devices for obtaining 
the R-R signal [24], and/or software for the data processing 
(i.e., selection and analysis) and artefact detection [6, 7, 49]. 
Therefore, this could indicate that such HRV differences 
(e.g., inter-days and/or intra-day differences) may be attrib-
utable, among other reasons, to the biological differences 
of subjects rather than to the HRV-derived parameter 
itself. In summary, and considering all together, there is 
a necessity to understand better whether some of the 
HRV-derived parameters are more reproducible than oth-
ers. Thus, it is mandatory to identify the most reproducible 
HRV-derived parameters considering different issues that 
have a direct influence (the health status of participants, 
the device used to assess the R-R signal, among others) 
to establish them as ‘good markers’ independently of the 
period between assessments.
R-R SIGNAL ARTEFACT CORRECTION AND ITS 
INFLUENCE ON HRV-DERIVED PARAMETERS
Once the R-R signal has been measured, the data is trans-
ferred to a computer for further processing [8]. Importantly, 
both the sampling frequency and the accuracy of the 
algorithm that “searches” the R wave (i.e., R peak) are funda-
mental factors for obtaining an accurate R-R signal. Theoret-
ically however, good algorithms are not so dependent on 
sampling frequency, and thus, a specific and high-quality 
HRV software is mandatory. This specific software allows 
the selection of the period (e.g., usually a 5 min period for 
short-term recordings) which will then be analyzed and 
used to derive the HRV parameters [1]. However, as certain 
artefacts that could negatively influence the R-R signal (and 
thus the HRV-derived parameters) may appear, artefact 
correction procedure has to be performed [8]. 
In a perfect situation, the R-R signal would be measured 
including only normal-to-normal (N-N) intervals, or in other 
words, “pure” sinus beats. Unfortunately, the R-R signal 
obtained from either HRM or ECG presents, in most cases, 
a diverse number of artefacts that may have a “technical” 
or a “biological” source [8]. When using HRM, technical ar-
tefacts may be introduced by a poor placement of the HRM 
band, movements from the subject, or may even be caused 
by sweating during the assessment. However, these tech-
nical artefacts in short-term R-R signal recordings, under 
well controlled and stable conditions, may not be common. 
On the other hand, biological artefacts may be introduced 
by ectopic beats or “abnormal” heart rhythms, which may 
appear even in healthy individuals [7, 8]. ECG verification 
is necessary to determine the presence of sinus rhythm, 
the presence or absence of arrhythmia (the most difficult 
are “late” supraventricular premature beats), the presence 
or absence of artifacts, and the origin of the shortest and 
longest R-R intervals. Besides, HR turbulence (visible in R-R 
intervals), is an interesting indicator to identify patients 
with autonomic dysfunction or impaired baroreflex sensi-
tivity. However, the current manuscript is not focused on 
heart rate turbulence. Regardless if artefacts are technical 
or biological, they represent an important problem as could 
influence either the HRV-derived parameters or their repro-
ducibility [8]. In this scenario, short-term R-R recordings 
contains approximately 300 R-R intervals [8]. From these 
R-R intervals, and although a small amount of them (≤5%) 
might be interpolated or deleted because of artefacts, they 
could affect the quantification of HRV-derived parameters 
in both time and frequency domain [8].
For the abovementioned reasons, an appropriate R-R 
signal artefact correction procedure is needed. Unfortu-
nately, nowadays there is no agreement regarding these 
procedures and what is the best way to correct such 
artefacts [8]. To handle the R-R signal data processing, di-
verse software can be used (e.g., Kubios, gHRV, ARTiiFACT, 
KARDIA, etc.) [49]. The Kubios software [10], is probably 
one of the most-frequently used tool in both clinical and 
research settings [7]. The Kubios software may correct the 
artefacts using their “threshold-based artefact correction” 
(or Kubios filters) algorithms [10]. In brief, these “filter” al-
gorithms compare each R-R interval value against a local 
average interval (obtained by median filtering the R-R 
interval time series) which is not influenced by outliers R-R 
intervals [7]. Therefore, if such an interval differs from the 
local average interval more than a pre-defined threshold 
value (depending on the “intensity” of threshold-based 
artefact correction algorithm used), the interval is consid-
ered as an artefact and is marked for correction by the soft-
ware [10]. The influence of the different threshold-based 
artefact correction algorithms has been recently studied 
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[7] in three different cohorts [7]. In their study, Alcantara 
et al. [7] concluded that the application of the Kubios 
threshold-based artefact correction algorithms had a sig-
nificant influence on the quantification of the HRV-derived 
parameters obtained from short-term recordings in both, 
time and frequency domains. Moreover, although the 
study design precluded the “definitive” recommendation 
of a threshold-based artefact correction algorithm [7], 
the study suggested to use the Very Low, Low or Medium 
threshold-based artefact correction algorithms in children 
and young adults. In contrast, any threshold-based artefact 
correction algorithm (with caution when using the Very 
Strong) may be employed for middle-aged adults.
Importantly, in most cases, each study uses a different 
software and artefact correction procedure, which could 
lead to problems in between studies comparisons [8]. 
These problems may be related to the greater or lesser 
amount of filtered/interpolated R-R intervals, which may 
vary between each software [49]. Furthermore, the sub-
ject’s (e.g., age, sex, health status, etc.) [50, 51], the length 
of recordings (e.g., short-term recordings vs ultra-short 
or 24 h recordings) [1,2], and even a researcher involved 
in the data selection and analysis of R-R signals [6] may 
influence the the comparison between studies. Regarding 
the “researcher influence”, previous studies  have shown 
that both, the intra- and inter-researcher differences (i.e., 
intra- and inter-researcher reproducibility) in the data 
selection and analysis (using short-term recordings) pro-
cess are not large [6, 44]. However, the inter-researcher 
variability could induce significant differences, being 
them clinically relevant, in the time domain HRV-de-
rived parameters [6, 44]. Therefore, the HRV signal data 
selection and processing should be carried out by the 
same researcher in order to obtain more reproducible 
HRV-derived parameters [6, 44].
Considering it all together, studies are needed to 
determine the best software and procedures to correct 
artefacts that may be present on R-R signals, and, con-
sequently, in the HRV-derived parameters, to establish 
more standardized recommendations for both clinicians 
and researchers.
OTHER METHODOLOGICAL 
CONSIDERATIONS FOR SHORT-TERM HRV 
RECORDINGS AT RESTING
We have described some methodological aspects that 
should be considered when HRV is measured. However, 
other methodological issues deserved some attention. 
Previous conditions. Commonly, the previous con-
ditions before the R-R signal assessment [52] are the fol-
lowing: (1) avoiding food intake (i.e., fasting), and coffee, 
tea, or caffeinated drinks intake at least 2 hours before the 
assessment; (2) avoiding intense physical activity at least 
2 hours before; (3) not drinking alcoholic beverages at least 
24 hours before the assessment; (4) sleeping as normal as 
possible (i.e., sleep duration and sleep schedule). Impor-
tantly, no control of these issues could bias the HRV-derived 
parameters [52].
Body positioning. Importantly, while resting, the body 
position (lying, sitting or standing) during the assessment 
could directly influence the quantification of the HRV-de-
rived parameters [53, 54]. Specifically, the change of the 
position from lying supine or seated to standing rest de-
creased the HRV-derived parameters (mainly in frequency 
domain) and increased the HR in healthy young adults 
[53]. The reason for this is that in a vertical position, the 
sympathetic tone is higher than vagal tone. In contrast, in 
a lying supine position, the vagal tone predominates over 
the sympathetic tone [55]. 
Respiration. “Controlling” the subject’s respiration (i.e., 
respiratory frequency; the number of breaths per minute) 
during the HRV assessment has been a methodological 
issue with certain disagreement among researchers. In 
fact, nowadays there is no consensus in the literature [52]. 
It should be noted that the HRV parameters quantifica-
tion could be affected by the respiratory frequency and 
its depth (the amount of air taken into the lungs; deep 
vs shallow breathing) [1, 52]. For example, the HF or the 
“respiratory” band reflects vagal tone from 0.15 to 0.40 Hz, 
which corresponds to a respiratory frequency from 9 to 
24 breaths per minute [1, 52]. Thus, a respiratory frequen-
cy below 9 or above 24 breaths per minute (0.15–0.40 Hz 
respectively) may impair the vagal tone quantification us-
ing the HF band [1, 52]. Considering this, the HRV-derived 
parameters that reflect vagal tone (while resting) in the 
frequency domain (e.g., HF band) are more influenced by 
the respiratory frequency compared to these derived from 
the time domain (e.g., RMSSD) [56]. However, “controlling” 
the respiratory frequency, or in other words “telling the 
subjects to breath at a specific frequency”, is controversial. 
In this regard, removing the inherent variance associated 
with the respiration pattern could “artificially” remove the 
variance associated with the common neural origin of the 
respiration and HRV [52, 57]. Otherwise, the impact of the 
respiration frequency on the quantification of the HRV-de-
rived parameters that reflect vagal tone is minimal when 
the HRV assessment is performed at resting state [58, 59].
Room conditions (temperature, humidity, light, time 
of day). Prior to assessing the R-R signal we should consider 
the ambient conditions of the room where the assessment 
will be performed as they may affect it. For example, the 
HRV-derived parameters decrease in response to heat 
stress in healthy adults [60, 61]. Similarly, 2 hours of passive 
heat exposure produced a reduction of the HRV-derived 
parameters that reflect vagal tone (e.g., RMSSD and HF) 
in healthy children [62]. Besides, sweat-induced fluid loss 
may increase cardiovascular work [63] due to dehydration, 
while appropriate hydration (i.e., higher total body water) 
during resting is positively associated with vagal tone [64]. 
On the other hand, it is recommended to assess the R-R 
signal using dim lighting because bright lights may affect 
the autonomic nervous system activity during the resting 
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assessments [65]. Thus, modifications in light intensity and 
color may have an impact on the HRV parameters [66, 67]. 
Lastly, it is known that time of day (morning vs night) might 
influence the HRV-derived parameters because vagal tone 
is increased at nighttime compared to the rest of the day 
[68]. Therefore, in general terms, the HRV-derived param-
eters decrease by day and tend to increase at night [68]. 
Nevertheless, another study [54] suggests the contrary. 
In fact, Vila et al. [54] observed that the HRV parameters 
decreased from morning to night. Further, they advise to 
recording the R-R signal (early) in the morning as diverse 
factors that may affect the HRV could be avoided (e.g., food, 
coffee and/or alcohol ingestion, fatigue, etc.).
Time interval data selection procedure. Studies using 
short-term recordings usually record the R-R signal during 
a period of 10 to 15 minutes. Then, either a pre-fixed interval 
(e.g., from the 10th to the 15th min period) or the “best qual-
ity period” (e.g., the 5 minutes period or higher quality) is 
selected to derive the HRV parameters [6, 69]. Although the 
criteria to select the “best period” are somehow subjective, 
this data selection procedure may be interesting. In fact, 
using this approach, the researcher select (after a visual 
inspection of the R-R signal) the best period based on the 
following criteria [6]: (1) less amount of large R-R interval 
outliers included in the selected period (those included 
will be then corrected using a specific HRV software); (2) 
R-R intervals equidistance; and, (3) R-R intervals distribu-
tion graphs as similar as possible to Gaussian distribution. 
Interestingly, it has been shown that the duration of the 
signal (i.e., using different pre-fixed intervals [e.g., 2, 5, 10, 
or 15 minutes]) used to derive the HRV parameters directly 
impacted their quantification (the shorter the interval, 
the higher the random measurement error) [70]. Lastly, 
and before performing any statistical analysis, we should 
consider that the HRV-derived parameters are not normally 
distributed [52]. Therefore, the HRV-derived parameters are 
commonly transformed using the natural logarithm [71], al-
though other transformations or “normalization” procedures 
have been proposed (e.g., log10, normal scores) [16, 72].
These methodological aspects that have been de-
scribed should be extensively studied to determine their 
“real” impact on various HRV-derived parameters and their 
validity and reproducibility, to further establish standard-
ized recommendations among the scientific community 
and general HRV users.
THE ROLE OF HR ON HRV ANALYSIS
The HRV parameters derived from R-R intervals are 
negatively correlated with an average HR. However, this 
relationship is both physiologically and mathematically 
determined [11–13]. The physiological mechanisms are 
based on the autonomic nervous system activity, but the 
mathematical one is caused by the non-linear (inverse) 
relation between R-R intervals and HR — Figure 1 [73]. 
For that reason, slow HR usually exhibits higher HRV (i.e., 
higher variability of R-R intervals) than fast HR, and hence, 
the HRV analysis may be mathematically biased [11]. 
Moreover, if HRV is so strongly associated with HR, some 
of its clinical and physiological meanings must originate 




















40 80 90 110 120 130100 140 150 160
Figure 1. The non-linear (mathematical) relationship between R-R interval and heart rate. The oscillations of slow heart rate (x-axis, dark gray 
area; Δ20 bpm) result in greater oscillations of R-R intervals (y-axis, dark gray area; 300 ms) compared to the same heart rate oscillations of 
a fast heart rate (light gray area: x-axis Δ20 bpm and y-axis 100 ms) [13]. Modified from  [12].
Abbreviations: ms, milliseconds; bpm, beats per minute
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published highlighting this relationship between HRV and 
HR, where authors summarized that the HRV is essentially 
determined by HR and cannot be used “independently” of 
it to outline the cardiac autonomic tone [74]. Therefore, 
to explore the HR impact on HRV and check whether the 
differences in HRV between subjects presenting different 
HR are due to actual differences in variability or simply 
due to differences in HR, one should “correct” HRV for the 
prevailing HR (i.e., normalize the fluctuations with respect 
to the mean R-R interval) [73]. In fact, the mathematical bias 
may be removed by dividing the R-R interval signal by the 
average R-R interval, or by dividing the HRV parameters 
by appropriate powers of the average R-R interval (e.g., 
for spectral parameters the power should be 2) [11, 12]. 
However, in order to completely remove the HRV depend-
ence on HR (i.e., even the physiological association), one 
should divide the HRV parameters by higher powers of the 
mean R-R interval [73]. On the other hand, one may also 
strengthen the HRV dependence on HR by multiplying R-R 
interval signals or HRV parameters by average R-R intervals 
[73]. Such approaches allow researchers to explore the HR 
contribution to the physiological and clinical significance 
of HRV [75, 76].
Several studies employed the abovementioned correc-
tion methods [73] to explore the interaction between HR 
and its variability. In particular, the relationship between 
HRV and HR is crucial when studying cohorts with different 
HR, such as men and women. In fact, rapid HR has been 
shown to overshadow the prognostic value of HRV in 
women; however, it may be uncovered if the effect of HR is 
excluded [77]. In other words, the normalization procedure 
and the exclusion of the influence of HR can act as a “mag-
nifying glass” for HRV in females with fast HR (Figure 2) and 
enables us to see more prognostic information. On the other 
hand, the removal of the HR impact on HRV may diminish 
or even eliminate the clinical value of HRV in conditions or 
populations where HR is a strong risk factor [73, 75, 77]. In 
such cases, the prognostic value of HRV can be improved by 
strengthening the relationship between HRV and HR, and it 
has indeed been shown that multiplying the HRV-derived 
parameters by the mean R-R interval increases the ability 
of HRV to predict mortality in men, where HR was a strong 
risk factor for cardiac death [77].
Some studies employed the correction method ap-
proach [78] to investigate the associations of HRV-derived 
parameters with CRF [16] and body composition measures 
[79] in overweight or obese children. Interestingly, after 
correcting the HRV-derived parameters by HR (i.e., HRV-de-
rived parameters divided by average R-R interval) all the 
associations observed between HRV-derived parameters, 
Figure 2. The R-R interval signals taken from a man and a woman. The upper panel shows the original signals 
where the male heart rhythm is slow (mean HR = 55 bpm), but the female one is fast (mean HR = 100 bpm), con-
sequently, the R-R interval fluctuations have higher amplitudes (i.e., higher HRV) in the man than in the woman. 
However, after the normalization to the average R-R interval (lower panel), both rhythms present comparable 
amplitudes — the normalization procedure acts like a magnifying glass for the variability of fast HR
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CRF, and body composition disappeared [16, 79]. Similarly, 
Grant et al. [80] concluded similar results addressing the 
associations between HRV-derived parameters corrected by 
HR (i.e., HRV-derived parameters divided by average R-R in-
terval) and CRF in healthy young adults, meaning HR is more 
strongly associated with CRF compared to any HRV-derived 
parameter. The conclusion reported by Grant et al. [80] was 
recently confirmed by an experiment conducted in healthy 
young adults [81]. Likewise, another recent study showed 
how most of the associations between cardiometabolic 
syndrome markers (i.e., glucose, triglycerides, etc.) and 
HRV-derived parameters disappeared after including HR 
as a covariate in multiple regression models in three inde-
pendent human cohorts (especially in children and young 
adults) [82]. In summary, the associations of HRV parame-
ters with CRF, body composition and metabolic syndrome 
markers were partially explained by HR in children with 
weight disturbances and healthy young adults [16, 79–83].
CONCLUSION
In conclusion, researchers and clinicians should consider 
several methodological aspects to appropriately quantify 
and interpret the HRV-derived parameters at resting con-
ditions using data from short-term recordings (Figure 3). 
Finally, and based on the possible influence that these 
methodological issues may have on the R-R signal deter-
mination and the HRV-derived parameters, we encourage 
researchers to describe the R-R signal acquisition and 
processing in detail, this would allow better comparisons 
across studies and robust conclusions when the short-term 
HRV-derived parameters are used.
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